Cosmos Health Inc. (COSM) P/E Ratio History
Historical price-to-earnings valuation from 2013 to 2020
Loading P/E history...
COSM Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Cosmos Health Inc. (COSM) trades at a price-to-earnings ratio of -0.3x, with a stock price of $0.35 and trailing twelve-month earnings per share of $-0.61.
The current P/E is 132% below its 5-year average of 0.9x. Over the past five years, COSM's P/E has ranged from a low of 0.8x to a high of 1.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, COSM trades at a 101% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, COSM trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our COSM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
COSM P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $134M | 32.2 | 7.51 | +16% | |
| $2B | 36.3 | 4.85 | +1883%Best | |
| $4B | 62.4 | - | +158% | |
| $92B | 29.2Lowest | 0.75Best | +15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
COSM Historical P/E Data (2013–2020)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2020 Q4 | $1.27 | $1.62 | 0.8x | +279% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $3.52 | $3.26 | 1.1x | +421% |
| FY2015 Q2 | $0.00 | $9.03 | 0.0x | -100% | |
| FY2015 Q1 | $0.00 | $11.79 | 0.0x | -100% | |
| FY2014 Q4 | Wed Dec 31 2014 00:00:00 GM | $0.00 | $13.23 | 0.0x | -100% |
| FY2014 Q3 | $0.00 | $15.76 | 0.0x | -100% | |
| FY2014 Q2 | Mon Jun 30 2014 00:00:00 GM | $0.00 | $5.56 | 0.0x | -100% |
| FY2014 Q1 | Mon Mar 31 2014 00:00:00 GM | $0.00 | $2.89 | 0.0x | -100% |
| FY2013 Q4 | $0.00 | $1.09 | 0.0x | -100% |
Average P/E for displayed period: 0.2x
See COSM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COSM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COSM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOSM — Frequently Asked Questions
Quick answers to the most common questions about buying COSM stock.
Is COSM stock overvalued or undervalued?
COSM trades at -0.3x P/E, below its 5-year average of 0.9x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does COSM's valuation compare to peers?
Cosmos Health Inc. P/E of -0.3x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is COSM's PEG ratio?
COSM PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2013-2020.